Skip to main content
. 2025 Dec 11;104(12):6327–6337. doi: 10.1007/s00277-025-06531-7

Table 2.

Population protocols description

Patients
VEN Protocol N Percentage
Initial dosage (mg)
100 2 4%
100* 7 15%
200 2 4%
400 37 77%
Initial duration (j)
7 5 10%
14 21 44%
21 10 21%
28 12 25%
Standard Protocol
400 mg for 28 days 11 23%
Start protocol modification
Dosage 4 8%
Duration 5 10%
Dosage and duration 1 2%
Cycle VEN duration
[1–3] 23 48%
[4–9] 15 31%
> 9 10 21%

* Combined with posaconazole